Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Clinical Oncology

• Publication date

  2011-06-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2010.34.1909PMID 21555697
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• How I treat HIV-associated multicentric Castleman disease.

  2010cited by this paper
• HIV-associated multicentric Castleman disease

  2009cited by this paper
• The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease.

  2009cited by this paper
• Multicentric Castleman's disease in HIV infection: a systematic review of the literature.

  2008cited by this paper
• Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.

  2008cited by this paper
• Rituximab failure in fulminant multicentric HIV/human herpesvirus 8-associated Castleman's disease with multiorgan failure: report of two cases.

  2008cited by this paper
• Plasmablastic microlymphoma occurring in human herpesvirus 8 (HHV‐8)‐positive multicentric Castleman's disease and featuring a follicular growth pattern

  2007cited by this paper
• Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.

  2007cited by this paper
• Brief Communication: Rituximab in HIV-Associated Multicentric Castleman Disease

  2007cited by this paper
• Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.

  2007cited by this paper
• Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders

  2006cited by this paper
• Failure of rituximab in human immunodeficiency virus‐associated multicentric Castleman disease

  2005cited by this paper
• Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment.

  2004cited by this paper
• Failure of cidofovir in HIV-associated multicentric Castleman disease.

  2004cited by this paper
• Rituximab therapy for HIV-associated Castleman disease.

  2003cited by this paper
• High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.

  2002cited by this paper
• Quantification of human herpesvirus 8 by real‐time PCR in blood fractions of AIDS patients with Kaposi's sarcoma and multicentric Castleman's disease

  2002cited by this paper
• Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy.

  2001cited by this paper
• Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.

  2001cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors

  2000cited by this paper
• Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy.

  2000cited by this paper
• HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma.

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

  2000cited by this paper
• High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

  2000cited by this paper
• Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma.

  1999cited by this paper
• Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells.

  1997cited by this paper
• Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies.

  1996cited by this paper
• Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients

  1996cited by this paper
• Lymphadenopathy in HIV infection: histological classification and staging.

  1989cited by this paper
• Multiple-organ failure. Generalized autodestructive inflammation?

  1985cited by this paper
• Multiple organ failure.

  1977cited by this paper
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

  1977cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• EBV+ and Kaposi’s Sarcoma Herpesvirus‐Associated Multicentric Castleman Disease in a Patient With HIV Infection: A Case Report

  2026cites this paper
• So behandle ich den Morbus Castleman

  2025cites this paper
• Updates on Kaposi Sarcoma.

  2025cites this paper
• Parotid Castleman's disease: A case report and literature review.

  2025cites this paper
• Characteristics and outcomes of Kaposi sarcoma herpesvirus–associated inflammatory cytokine syndrome

  2025cites this paper
• Fifth edition WHO classification: mature B-cell neoplasms

  2025cites this paper
• Disseminated nocardiosis in a patient with AIDS and B-cell non-Hodgkin’s lymphoma: a case report

  2025cites this paper
• Management of KSHV/HHV8 positive Multicentric Castleman Disease concurrent with other KSHV/HHV8 positive disorders. An emergent challenge in PLWH.

  2025cites this paper
• Fifth subtype of Kaposi sarcoma in HIV-negative MSM: a retrospective single-arm cohort study from a tertiary care center in NYC from 2000 to 2022

  2025cites this paper
• Kaposi sarcoma herpesvirus (KSHV) inflammatory cytokine syndrome (KICS): a case study

  2025cites this paper
• Non‐Clonal Lymphoproliferative Diseases

  2025cites this paper
• Castleman disease

  2025cites this paper
• Human Herpes Virus-8 Oral Shedding Heterogeneity Is Due to Varying Rates of Reactivation from Latency and Immune Containment

  2025cites this paper
• Clinical Presentation, Treatment, and Outcomes of 28 Patients With Castleman Disease: A Retrospective Analysis of an Italian Cohort

  2025cites this paper
• A Review of KSHV/HHV8-Associated Neoplasms and Related Lymphoproliferative Lesions

  2025cites this paper
• HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus

  2024cites this paper
• Overview of Research Status in Castleman Disease.

  2024cites this paper
• Pacritinib inhibits proliferation of primary effusion lymphoma cells and production of viral interleukin-6 induced cytokines

  2024cites this paper
• The aggravating fury rituximab obliterated

  2024cites this paper
• Immune deficiency/dysregulation -associated lymphoproliferative disorders. Revised classification and management.

  2024cites this paper
• Human Herpes Virus-8 Oral Shedding Heterogeneity is Due to Varying Rates of Reactivation from Latency and Immune Containment

  2024cites this paper
• Hemophagocytic lymphohistiocytosis in HIV-associated HHV8-positive multicentric castleman disease.

  2024cites this paper
• Viral Load Measurements for Kaposi Sarcoma Herpesvirus (KSHV/HHV8): Review and an Updated Assay

  2024cites this paper
• HHV8-Associated Multicentric Castleman Disease: A Case Report on a Rare Complication of HIV in a Low-Income Setting

  2024cites this paper
• The Cytokine Storm of Multicentric Castleman Disease.

  2024cites this paper
• Unexpected diagnosis of rare mesenteric Castleman disease: A case report and literature review

  2024cites this paper
• Human Herpesvirus-8 Positive Multicentric Castleman’s Disease with Complete Response after Rituximab Monotherapy: A Case Report

  2023cites this paper
• Multicentric Castleman disease of hyaline‑vascular variant with paraneoplastic pemphigus results in abnormal lung function: Report of 3 cases

  2023cites this paper
• Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies

  2023cites this paper
• A Challenging Case of Kaposi Sarcoma Inflammatory Cytokine Syndrome

  2023cites this paper
• Outcomes in Kaposi's sarcoma‐associated herpesvirus ‐associated primary effusion lymphoma and multicentric Castleman's disease in patients with human immunodeficiency virus (HIV) in a safety‐net hospital system

  2023cites this paper
• A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab

  2023influential citation
• Higher rate of progression in HIV– than in HIV+ patients after rituximab for HHV8+ multicentric Castleman disease

  2023cites this paper
• Enfermedad de Castleman multicéntrica e infección por virus Epstein Barr en paciente con infección por vih

  2023cites this paper
• Case report: Multicentric Castleman disease as a manifestation of immune reconstitution inflammatory syndrome in Malawi

  2022cites this paper
• Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease

  2022cites this paper
• Multicentric Castleman's disease in kidney transplant: A case report and literature review.

  2022cites this paper
• Castleman’s disease associated with bronchopulmonary cancer: consequence or coincidence? (About two cases)

  2022cites this paper
• Human Oncoviruses and Thoracic Tumors: Understanding the Imaging Findings.

  2022cites this paper
• TAFRO syndrome with fatigue and abdominal distension as the first symptom: A case report

  2022cites this paper
• HHV-8-Associated Multicentric Castleman Disease, a Diagnostic Challenge in a Patient With Acquired Immunodeficiency Syndrome and Fever

  2022cites this paper
• Treatment and Outcome of Castleman Disease: A Retrospective Report of 31 Patients

  2022cites this paper
• Characteristics of patients admitted to the ICU with Kaposi sarcoma herpesvirus-associated diseases

  2022cites this paper
• Long-term treatment outcome of Castleman’s disease: A real-world experience

  2022cites this paper
• HHV-8-associated multicentric Castleman disease with concurrent Kaposi sarcoma

  2022cites this paper
• A rare HIV-associated hyaline vascular multicentric castleman disease with good early response to single-agent rituximab: A case from Tanzania

  2022cites this paper
• Cytology of Castleman's disease (hyaline-vascular type) masquerading as Hodgkin's lymphoma.

  2022cites this paper
• Recent Advances in Castleman Disease

  2022cites this paper
• Multicentric Castleman Disease: The Hyaline Vascular Type Without HIV Association in a Young Male With Cutaneous Manifestation and Renal Impairment

  2022cites this paper
• Concurrent HIV viral blips during two episodes of multicentric Castleman disease in an adult on antiretroviral therapy: Implication for HIV persistence

  2021cites this paper
• Morbus Castleman – ein seltenes, heterogenes Krankheitsbild

  2021cites this paper
• An Immunocompetent HIV-Negative Elderly Patient with Low-Grade Fever, Generalized Lymphadenopathy, Splenomegaly, and Acute Phase Response: Do Not Forget Castleman Disease

  2021cites this paper
• Multicentric Castleman’s disease in HIV patients: a single-center cohort diagnosed from 2008 to 2018

  2021influential citation
• Idiopathic multicentric Castleman disease: pathogenesis, clinical presentation and recommendations for treatment based on the Castleman Disease Collaborative Network (CDCN)

  2021cites this paper
• Advances in the Study of Kaposi’s Sarcoma in Human

  2021cites this paper
• The management of Castleman disease

  2021influential citation
• KSHV/HHV8-mediated hematologic diseases.

  2021cites this paper
• HIV-associated lymphoma—advances in clinical management

  2021cites this paper
• A Rare Lymphoproliferative Disease: Castleman Disease

  2021cites this paper
• Human herpesvirus 8-associated multicentric Castleman disease in a patient with advanced HIV infection

  2021influential citation
• Hemoglobin and C-reactive protein levels as predictive factors for long-term successful glucocorticoid treatment for multicentric Castleman’s disease

  2020cites this paper
• Overview of Castleman Disease.

  2020cites this paper
• Epidemiology of haematological malignancies in people living with HIV.

  2020cites this paper
• Misdiagnosing multicentric Castleman's disease in an HIV-positive patient.

  2020cites this paper
• Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

  2020cites this paper
• Castleman病的诊疗进展

  2020cites this paper
• Recurrent and Hodgkin’s lymphoma-associated multicentric Castleman’s disease in head and neck region

  2020cites this paper
• Evaluation of the therapeutic potential of several compounds in human herpesvirus 8 using a chimera virus mouse infection model

  2019cites this paper
• Plasmablastic Lymphoma and Primary Effusion Lymphoma

  2019cites this paper
• Castleman Disease

  2019cites this paper
• Multicentric Castleman disease as a rare cause of nephrotic syndrome : a case report

  2019cites this paper
• Kaposi sarcoma

  2019cites this paper
• 36 – Lymphadenopathy and Neck Masses

  2018cites this paper
• Castleman’s disease in the HIV-endemic setting

  2018cites this paper
• Castleman’s Disease

  2018cites this paper
• Hodgkin’s lymphoma and its association with EBV and HIV infection

  2018cites this paper
• Isolated retroperitoneal Castleman's disease: A case report and literature review

  2018cites this paper
• Biologic Agents in the Treatment of Multicentric Castleman Disease.

  2018cites this paper
• AIDS-Associated Malignancies.

  2018cites this paper
• Treatment of Idiopathic Castleman Disease.

  2018cites this paper
• GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus.

  2018cites this paper
• Castleman Disease Pathogenesis.

  2018cites this paper
• Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.

  2018cites this paper
• Diagnosis of Castleman Disease.

  2018cites this paper
• Comprehensive analysis of 225 Castleman’s diseases in the oral maxillofacial and neck region: a rare disease revisited

  2018cites this paper
• Castleman's disease

  2018cites this paper
• Interaction between DC-SIGN and DC-SIGNR with HHV-8 (LANA-1) and HIV-p24 in Castleman disease

  2018influential citation
• The unholy trinity of human herpesvirus 8-associated malignancy in a person living with HIV-1.

  2018cites this paper
• Intrathoracic Castleman's disease: “An important clinical mimicker”

  2017cites this paper
• Siltuximab and hematologic malignancies. A focus in non Hodgkin lymphoma

  2017cites this paper
• Viral Diseases of the Skin

  2017cites this paper
• Therapeutic outlook for Castleman’s disease: prospects for the next decade

  2017cites this paper
• Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases

  2017cites this paper
• Kaposi sarcoma herpesvirus pathogenesis

  2017influential citation
• HIV-associated Kaposi sarcoma and related diseases

  2017cites this paper
• Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients

  2017influential citation
• Fever and generalised lymphadenopathy in an HIV-positive patient: a diagnostic challenge

  2017cites this paper
• Experience with Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome in a Large Urban HIV Clinic in the United States: Case Series and Literature Review

  2017cites this paper
• Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients.

  2017influential citation
• Successful Treatment of Kaposi Sarcoma–Associated Herpesvirus Inflammatory Cytokine Syndrome After Kidney–Liver Transplant: Correlations With the Human Herpesvirus 8 miRNome and Specific T Cell Response

  2017influential citation